Publications by authors named "Gha-Hyun J Kim"

Compound K (CK), a ginsenoside with high bioavailability, is present at low levels in wild-simulated ginseng leaves (WSGL). WSGL contains the CK precursors, Rd and F2, in amounts up to 26.4 ± 0.

View Article and Find Full Text PDF
Article Synopsis
  • A new screening method for discovering bioactive compounds is being tested using live zebrafish, which can help identify neuroprotective substances for dopaminergic neurons.
  • The protocol includes steps for raising zebrafish larvae, embedding them in agarose, and inducing neurodegeneration for study.
  • It also outlines techniques for performing live confocal imaging, processing the images, and analyzing the resulting data, with further details available in Kim et al. (2021).
View Article and Find Full Text PDF

Parkinson's disease (PD) is the second most common neurodegenerative disorder with prominent dopamine (DA) neuron degeneration. PD affects millions of people worldwide, but currently available therapies are limited to temporary relief of symptoms. As an effort to discover disease-modifying therapeutics, we have conducted a screen of 1,403 bioactive small molecule compounds using an whole organism screening assay in transgenic larval zebrafish.

View Article and Find Full Text PDF

Among cases of SARS-CoV-2 infections that result in serious conditions or death, many have pre-existing conditions such as hypertension and are on renin-angiotensin-aldosterone system (RAAS) inhibitors. The angiotensin-converting-enzyme-2 (ACE2), a key protein of the RAAS pathway, also mediates cellular entry of SARS-CoV-2. RAAS inhibitors might affect the expression levels of ace2, which could impact patient susceptibility to SARS-CoV-2.

View Article and Find Full Text PDF

Parkinson's disease (PD) is a common neurodegenerative disorder without effective disease-modifying therapeutics. Here, we establish a chemogenetic dopamine (DA) neuron ablation model in larval zebrafish with mitochondrial dysfunction and robustness suitable for high-content screening. We use this system to conduct an in vivo DA neuron imaging-based chemical screen and identify the Renin-Angiotensin-Aldosterone System (RAAS) inhibitors as significantly neuroprotective.

View Article and Find Full Text PDF